FindTrial
Sign In

Comparative Assessment of Lac vaccinum defloratum and Individualized Homoeopathic Medicine in treatment of Migraine without aura

Assessing the effectiveness of Lac vaccinum defloratum and Individualized Homoeopathic Medicine in the treatment of Migraine Without Aura - A comparative study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102565
Enrollment
70
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Individualized Homoeopathic Medicine and Lac vaccinum defloratum: Among 2 groups Lac vaccinum defloratum will be given to subjects having Lac vaccinum defloratum symptoms and remaining

Sponsors

Dr Pramodini Sahoo
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are voluntarily willing to participate and sign the written informed consent. Subjects aged between 19- 45 years.16 Subjects fulfilling international classification of Headache disorders criteria 3 for Migraine without aura.

Exclusion criteria

Exclusion criteria: Headaches with atypical features. Pregnant and lactating mothers. Subjects who are under medication from homoeopathy and any other system of medicine for the same complaints. Subjects diagnosed with other systemic illness other than Migraine without aura

Design outcomes

Primary

MeasureTime frame
Disappearance of symptoms of Migraine without auraTimepoint: By the end of 12 weeks—

Secondary

MeasureTime frame
Reduction of symptoms of Migraine without auraTimepoint: By the end of 24 weeks—

Countries

India

Contacts

Public ContactDr Pramodini Sahoo

Government Homoeopathic Medical College and Hospital Bengaluru

dr.praveen123@gmail.com9845301645

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026